Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries
H Goossens, M Ferech, S Coenen… - Clinical infectious …, 2007 - academic.oup.com
H Goossens, M Ferech, S Coenen, P Stephens…
Clinical infectious diseases, 2007•academic.oup.comAbstract The European Surveillance of Antimicrobial Consumption (ESAC) project collects
data on antibacterial use in Europe, applying the Anatomic Therapeutic Chemical
classification system and defined daily dose methodology, as recommended by the World
Health Organization. Comparable data for the United States have been collected from IMS
Health. The IMS Health sales data, processed according to ESAC methodology, suggest that
outpatient antibacterial use in the United States is high (only 3 of 27 European countries …
data on antibacterial use in Europe, applying the Anatomic Therapeutic Chemical
classification system and defined daily dose methodology, as recommended by the World
Health Organization. Comparable data for the United States have been collected from IMS
Health. The IMS Health sales data, processed according to ESAC methodology, suggest that
outpatient antibacterial use in the United States is high (only 3 of 27 European countries …
Abstract
The European Surveillance of Antimicrobial Consumption (ESAC) project collects data on antibacterial use in Europe, applying the Anatomic Therapeutic Chemical classification system and defined daily dose methodology, as recommended by the World Health Organization. Comparable data for the United States have been collected from IMS Health. The IMS Health sales data, processed according to ESAC methodology, suggest that outpatient antibacterial use in the United States is high (only 3 of 27 European countries used more) and is mainly characterized by a shift towards newer antibiotics.
Oxford University Press以上显示的是最相近的搜索结果。 查看全部搜索结果